• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - ENGLEWOOD ABACUS V3.2 SE; SYSTEM/DEVICE, PHARMACY COMPOUNDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - ENGLEWOOD ABACUS V3.2 SE; SYSTEM/DEVICE, PHARMACY COMPOUNDING Back to Search Results
Catalog Number 83000192
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Hyperglycemia (1905)
Event Date 02/23/2018
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.A baxter technical service representative (tsr) received the abacus event logs, compounder database, black box files, mix check reports, label, original label, and pat file folder.The tsr sent the information to support services.A complete review of the information showed that the user manually selected the patient order instead of using the bag label via the scanner.In doing so the user selected the wrong patient order.The compounder black box data was evaluated.Upon evaluation, there is no evidence that the em2400 compounder or the compounder software contributed to the user manually selecting the incorrect patient¿s order and pumping the tpn bags.The data provided shows that the bag produced by this compounder, without any environmental or physical interference, should have been acceptable for clinical use, except for it being for the wrong patient.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that an abacus v3.2 se printed a label with correct patient information, however when scanned on the compounder, a different patient formula was populated.The patient experienced hyperglycemia as a result with a blood glucose levels in the upper 500's.The intravenous infusion was stopped and the glucose level were checked frequently until they normalized.The corresponding mix check report also had the incorrect patient information listed.The customer stated that in abacus the order was created and completed and then they changed the patient name and re-printed the label.This event occurred during use of the device.No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABACUS V3.2 SE
Type of Device
SYSTEM/DEVICE, PHARMACY COMPOUNDING
Manufacturer (Section D)
BAXTER HEALTHCARE - ENGLEWOOD
englewood CO
Manufacturer (Section G)
BAXTER HEALTHCARE - ENGLEWOOD
14445 grasslands dr
englewood CO 80112
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key7367989
MDR Text Key103393417
Report Number1416980-2018-01581
Device Sequence Number1
Product Code NEP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Catalogue Number83000192
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/23/2018
Initial Date FDA Received03/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-